Massachusetts General Hospital Researchers and Prevencio Announce AI-driven HART® CVE Blood Test Accuracy for Patients with Coronary Chronic Total Occlusion
Researchers from Massachusetts General Hospital (MGH) tested 241 patients with chronic total occlusion of at least one coronary (heart) artery for the risk of a major adverse cardiac event, including non-fatal myocardial infarction, stroke, and cardiovascular death through four years follow up.
- Researchers from Massachusetts General Hospital (MGH) tested 241 patients with chronic total occlusion of at least one coronary (heart) artery for the risk of a major adverse cardiac event, including non-fatal myocardial infarction, stroke, and cardiovascular death through four years follow up.
- Using HART CVE risk scores, the high-risk patients were more than 12 times more likely to experience a myocardial infarction, stroke, or cardiovascular death as compared to low-risk patients.
- Approximately 25% of patients with obstructive heart disease have Chronic Total Occlusion or total blockage of a coronary heart artery.
- “HART CVE demonstrated robust accuracy for determining risk in these Chronic Total Occlusion patients.